FAIR VALUE REPORT
ALTRIA · MO · NOV 03, 2026 · AFTER RESULTS OF OCT 29, 2026
Does Altria at $77 need its tax refund to come back every quarter?
The quarter to September 2026 lifted the stock 5.2% and pulled three targets to $83-85. Most of the extra cigarette profit came from refunded duties, not from Marlboro. The model stops at $75.18 - and the gap hinges on whether the refund repeats.
FPI VERDICT · NOV 03, 2026
DCF 50% · RELATIVE 30% · CONSENSUS 20%
2.6%
at fair value
UNCERTAINTY
LOW ±10%
FAIR VALUE BAND
$67.66 – $82.70
PRICE VS BAND
INSIDE THE BAND
Numbers as of publication. Today's fair value and price: MO stock page → · How uncertainty is rated →
5 MIN READ
THE REPORT IN 3 POINTS
- 01A $124 million duty-drawback refund exceeded the entire $116 million rise in Altria's smokeable operating profit.
- 02At $77.17 on 2 November 2026 the stock trades 2.6% above FPI's $75.18 fair value and 9.7% above the $69.71 mean target.
- 03Marlboro shipments fell 6.4% and nine-month dividends plus buybacks of $6.0 billion exceeded $5.9 billion of free cash flow.
A $124 million refund outweighed the entire gain in cigarette profit
Altria ($MO) reported adjusted earnings of $1.52 a share for the quarter to September 2026, up 4.8%, on revenue net of excise taxes of $5.44 billion, up 3.6%, and raised its 2026 guidance to $5.66-5.74. The shares rose 5.2% on 29 October 2026.
The source of the beat is narrow. Smokeable adjusted operating income rose $116 million to $3.07 billion, driven by pricing and refunds of taxes and duties on imported cigarettes. The duty-drawback benefit alone was $124 million of revenue - more than the whole profit increase of the segment. Altria now makes cigarettes for export under contract - 1,595 million sticks against 311 million in the quarter to September 2025 - and the exports earn back duties and excise tax paid on imports.
Without the refund the brands are shrinking faster than the headline shows. Marlboro shipments fell 6.4% to 13,324 million sticks and its retail share slipped 1.0 point to 39.5%, while the industry's discount share climbed 2.0 points to 34.1%. Oral tobacco posted adjusted profit down 3.7% to $443 million with the margin down 2.8 points to 66.4%: Copenhagen volume fell 10.1%, Skoal 12.6%, and on! grew 13.3% yet lost 1.3 points of pouch share to 13.5%. The other prop was the Anheuser-Busch InBev stake: adjusted equity earnings up 21.7% to $191 million.
| REPORTED | REVENUE | VS EST. | EPS | VS EST. | PRICE REACTION |
|---|---|---|---|---|---|
| OCT 29, 2026 | $5.4B | +2.4% | $1.52 | +0.7% | +5.2% |
| JUL 30, 2026 | $5.4B | +0.2% | $1.48 | −1.3% | −9.3% |
| APR 30, 2026 | $4.8B | +3.9% | $1.32 | +5.6% | +6.5% |
| JAN 29, 2026 | $5.1B | +0.9% | $1.30 | −1.5% | −5.3% |
| OCT 30, 2025 | $5.3B | −0.8% | $1.45 | +0.7% | −7.8% |
| JUL 30, 2025 | $5.3B | +1.9% | $1.44 | +3.6% | +3.6% |
| APR 29, 2025 | $5.3B | +13.9% | $1.23 | +3.4% | +1.6% |
| JAN 30, 2025 | $5.1B | +1.2% | $1.29 | +0.8% | −0.8% |
Altria beat the EPS estimate in 6 of the last 8 quarters. Price reaction is the move on the trading day after the results.
The price is up 48% since the end of 2024 on 10% more earnings
Shares closed at $77.17 on 2 November 2026, against $52.29 on 31 December 2024 - a 48% gain. Adjusted earnings per share over the same span go from $5.19 in 2024 to a 2026 guidance midpoint of $5.70, up 10%. The rest came from investors paying more for each dollar of profit: price to free cash flow went from 10.4x to 15.5x, and the P/E of 15.8x now sits above the tobacco median of 15.4x.
Free cash flow in the nine months to 30 September 2026 was about $5.9 billion: operating cash flow of $6,151 million minus $259 million of capital spending, per the 10-Q. Dividends of $5.3 billion plus buybacks of $735 million came to $6.0 billion - more than the business generated. Cash fell from $4,474 million at 31 December 2025 to $2,697 million; long-term debt fell to $24,061 million, 1.9 times EBITDA. The board added $1 billion to the buyback program on 28 October 2026, but third-quarter repurchases averaged $68.52 - the current price is 12.6% higher, so each future dollar retires fewer shares.
Why the model stops at $75.18 - 2.6% under the price
The FPI fair value is $75.18, built from a discounted cash flow (50%), peer multiples (30%) and analyst consensus (20%). At $77.18 the stock sits 2.6% above it.
The DCF half is where Altria scores best. A free cash flow yield of 6.44%, a return on invested capital of 34.5% and a net margin of 36.8% - more than twice the tobacco median of 16.1% - are the inputs that lift a cash flow valuation. What caps it is growth: revenue has shrunk 0.9% a year over three years, guidance calls for 4.5-6.0% EPS growth, and the $4.44 annual dividend absorbed about 90% of nine-month free cash flow.
The peer leg has flipped. At 15.8x earnings and 12.5x EV/EBITDA - market value plus net debt over operating profit before depreciation - Altria now carries a premium to BTI (15.3x and 10.5x) and sits far above Imperial Brands at 10.9x, when it was the cheap one at 8.0x earnings at the end of 2024. The consensus leg, with a mean target of $69.71, pulls the blend down. At 13.5x the 2026 guidance midpoint, the price already assumes the second-half refund run rate continues.
Over the 120 days to November 3, 2026 the share price went from $71.89 to $76.92 (+7.0%) and the FPI fair value from $69.38 to $75.18 (+8.4%). The gap moved from 3.5% above fair value to 2.3% above.
Street vs model: a $71 median below the price, $85 above it
Twenty-six analysts cover the stock: 16 buy, 9 hold, 1 sell. Yet the median target on 30 October 2026 was $71, 8.0% below the price, and the mean $69.71, 9.7% below, with a range of $58 to $79. The Street as a whole has not moved its numbers up with the stock.
The three targets issued after the results say the opposite: UBS $83, Goldman Sachs $83 and Wells Fargo $85, all on 30 October 2026, an average of $83.67 - 8.4% above the price. Goldman's move from $77 to $83 rested on slower volume declines, a bigger drawback benefit and ABI income, with more expected once the PMI contract manufacturing arrangement starts shipping in early 2027; PMI's 24 August 2026 announcement states no material impact on 2026. The bears, Jefferies at $60 (2 October 2026) and Barclays at $58 (11 August 2026), priced the stock before the quarter.
The FPI value of $75.18 sits 7.8% above the consensus mean and 10.1% below the fresh targets. The difference is one assumption: whether the refund is a scalable earnings line that grows with PMI volumes in 2027, or a 2026 boost that flatters the base. The January guidance of $5.56-5.72 already weighted 2026 growth to the second half because of import and export activity, so the fourth quarter is the first real test of the run rate.
16 buy · 9 hold · 1 sell. FPI fair value sits inside the Street range, the share price is inside the range.
Three numbers to watch before 4 February 2027
Upside: the stock re-rates toward the fresh targets if the fourth-quarter drawback benefit lands near $124 million (the company's stated expectation is a fourth quarter in line with the third), adjusted EPS meets or beats the $1.39 estimate - guidance implies roughly $1.34-1.42 against $1.30 in the quarter to December 2025 - and PMI shipments start on schedule in early 2027.
Downside: the model's number holds or falls if discount share keeps climbing from 34.1%, on! pouch share slides further from 13.5%, or oral margins stay below 67% for a second quarter.
Price markers: the 52-week high of $79.81 is 3.4% away; the fair value of $75.18 is 2.6% below; the 200-day average of $68.96 is 10.6% below. One director bought 1,500 shares at $67.62 on 9 September 2026 - the only insider purchase in 12 months. At $77 the reader is paying for the refund to repeat; the number that proves it arrives on 4 February 2027.
TOP OF THE FPI FAIR VALUE BAND
- 01The fourth-quarter duty-drawback benefit lands near the $124 million booked in the quarter to September 2026, proving the refund is a run rate rather than a one-off.
- 02Adjusted EPS on 4 February 2027 meets or beats the $1.39 estimate against $1.30 in the quarter to December 2025, supporting the raised 2026 guidance of $5.66-5.74.
- 03PMI contract manufacturing shipments start on schedule in early 2027, backing the post-results targets from UBS, Goldman Sachs and Wells Fargo that average $83.67.
LOWEST WALL STREET TARGET
- 01Marlboro shipments fell 6.4% to 13,324 million sticks and its retail share slipped 1.0 point to 39.5% as industry discount share climbed 2.0 points to 34.1%.
- 02Dividends of $5.3 billion plus $735 million of buybacks totalled $6.0 billion against about $5.9 billion of nine-month free cash flow, and cash fell to $2,697 million.
- 03At 15.8x earnings and 12.5x EV/EBITDA Altria trades above BTI at 15.3x and 10.5x, after being the cheap name at 8.0x earnings on 31 December 2024.
FPI FAIR VALUE $75.18 · FPI fair value of $75.18 sits far closer to the $82.70 bull anchor than to the $58.00 bear case, and the deciding fact is whether the $124 million duty-drawback benefit repeats on 4 February 2027.
FPI fair value blends a discounted cash flow model (50%), relative valuation against sector peers (30%) and analyst consensus (20%), updated daily. How the model works →
TRACK THE NUMBER
Get notified when MO's fair value changes
Set your own buy price for MO and the app alerts you when the stock reaches it. iOS and Android.
MORE MO REPORTS
This is the first FPI fair value report on Altria. The next one follows the company's next quarterly results.
MORE REPORTS IN CONSUMER DEFENSIVE
- WMT · Walmart planned a 2% profit quarter. Why is it still priced at 46 times earnings?NOV 19, 2026
- TGT · Is Target still cheap once the $994 million refund leaves the earnings?NOV 18, 2026
- KO · The last time Coca-Cola cost 28x earnings, it went nowhere for two yearsOCT 27, 2026
- PG · Is P&G at $161 a bet that oil falls back to $100?OCT 26, 2026
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.





